Michael John Sumner - 18 Dec 2024 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Medical Officer
Signature
/s/ Michael John Sumner
Issuer symbol
INO
Transactions as of
18 Dec 2024
Net transactions value
$0
Form type
4
Filing time
18 Dec 2024, 19:01:52 UTC
Previous filing
01 Jul 2024
Next filing
28 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Option Award $0 +5,708 $0.000000 5,708 18 Dec 2024 Common Stock 5,708 $1.78 Direct F1
transaction INO Restricted Stock Unit Award $0 +4,292 $0.000000 4,292 18 Dec 2024 Common Stock 4,292 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options to vest 100% on March 31, 2026, subject to the reporting person's continuous service with the issuer through such date.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on March 31, 2026, subject to the reporting person's continuous service with the issuer through such date.